Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
Amgen Reinforcing Its Portfolio
02:47am, Tuesday, 17'th Jan 2023
Acquiring ChemoCentryx gave them TAVNEOS, the only approved drug for the rare autoantibody-associated vasculitis. A much bigger deal for Horizon Therapeutics brought in blockbuster TEPEZZA and 11 othe
Amgen: Dividend Growth Secure But Keep An Eye On Debt, Margins
06:01am, Saturday, 14'th Jan 2023
AMGN has been able to grow dividends at a rate of 11% over the past 5 years, even as the stock has gained 46% over this period. It looks set to continue growing dividends thanks to its strong balance
High Yield Stock Watchlist - January 2023
08:46am, Friday, 13'th Jan 2023
There are 15 stocks on my high yield watchlist for January 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
Ranking The 10 Largest Biotechs By Pipeline
12:34pm, Wednesday, 11'th Jan 2023
The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment
Amgen Inc. (AMGN) JP Morgan 41st Annual Healthcare Conference (Transcript)
12:42am, Tuesday, 10'th Jan 2023
Amgen Inc. (NASDAQ:AMGN ) JP Morgan 41st Annual Healthcare Conference Call January 9, 2023 6:45 PM ET Company Participants Bob Bradway - Chairman & Chief Executive Officer Conference Call Participants
Dividend Income Update: December 2022
12:30am, Tuesday, 10'th Jan 2023
Dividend investing can work over time and anyone can create an ever growing passive income stream. My year over year progress is moving at a nice clip.
Ranking The Top 10 Pharmaceuticals By Pipeline
11:44pm, Monday, 09'th Jan 2023
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance.
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
01:33pm, Monday, 09'th Jan 2023
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Dogs Of The Dow 2023: 10 Blue-Chip Bargains
09:45am, Sunday, 08'th Jan 2023
Not only did they outpace the market, but they delivered positive gains!
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
06:26pm, Friday, 06'th Jan 2023
Not every stock went down in 2022. Shares in some the biggest pharmaceutical companies rose in price.
Healthcare Stocks Had a Strong 2022. It Isn't Too Late to Buy.
03:49pm, Thursday, 05'th Jan 2023
Profits in the sector tend to be stable even if hard times hurt earnings elsewhere, so the current high inflation and rising rates, represent a chance for the shares to shine.
'Dogs Of The Dow' Stocks Just Paid Off; Here Are The Top 10 For 2023
08:00am, Thursday, 05'th Jan 2023
Owning the "Dogs Of The Dow" stocks paid off in 2022. And they could be even more lucrative this year.
The 10 Best Dividend Stocks of All Time
12:30pm, Wednesday, 04'th Jan 2023
Any discussion regarding the best dividend stocks of all time often starts with the Dividend Aristocrats. They are S&P 500 companies that have increased their annual dividend payment for at least 25 c
Buy 4 January Dogs Of The Dow, Watch 4 More
09:42pm, Tuesday, 03'rd Jan 2023
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.�
